is semaglutide red Ozempic: What Does It Do and How Do I Use It? MEDICAL WEIGHT LOSS GLP1 SEMAGLUTIDE

Treatment continuation is reviewed at regular intervals

Aspiration pneumonia has been reported

Proper licensing is non-negotiable

As Bayer previously highlighted in their topline data announcement, the FINEARTS trial met its primary endpoint, with use of finerenone associated with a statistically significant 16% relative reduction in rate of primary outcome events compared with placebo therapy (rate ratio [RR], 0.84

4 This evidence supported the MHRAs decision to extend Wegovys licence in July 2024 to include reducing the risk of serious heart events in adults living with overweight or obesity and established cardiovascular disease

22 (6), 13302 e4